Ethinylestradiol (ethinylestradiol): Reviews and patient testimonials

Ethinylestradiol Tablets BP 1 mg

Post menopausal symptoms due to estrogen deficiency.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Palliative treatment of prostatic cancer.

Hormone replacement therapy for failure of ovarian development e.g. in patients with gonadal dysgenesis where initial estrogen therapy is later followed by combined estrogen/progestogen therapy.

Disorders of menstruation, given in conjunction with a progestogen.

(See also Section 4.4).

Ethinylestradiol Tablets BP 10 mcg

Post menopausal symptoms due to estrogen deficiency.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Palliative treatment of prostatic cancer.

Hormone replacement therapy for failure of ovarian development e.g. in patients with gonadal dysgenesis where initial estrogen therapy is later followed by combined estrogen/progestogen therapy.

Disorders of menstruation, given in conjunction with a progestogen.

(See also Section 4.4).

Ethinylestradiol Tablets BP 50 mcg

Post menopausal symptoms due to estrogen deficiency.

Prevention of osteoporosis in postmenopausal women at high risk of future fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of osteoporosis.

Palliative treatment of prostatic cancer.

Hormone replacement therapy for failure of ovarian development e.g. in patients with gonadal dysgenesis where initial estrogen therapy is later followed by combined estrogen/progestogen therapy.

Disorders of menstruation, given in conjunction with a progestogen.

(See also Section 4.4).
Route of administration: Oral
Molecule: ethinylestradiol